MassChallenge

HeroSupport is a medical device manufacturing company founded in 2019 and based in Veyrier, Geneva. The company specializes in creating medical immobilization devices designed to enhance patient comfort during clinical procedures. Its innovative technology transforms imaging and treatment tables into personalized support solutions, specifically catering to the needs of patients undergoing prone breast radiotherapy. This approach allows patients to benefit from tailored support, eliminating the need for them to adjust to the standard table. By improving patient comfort, HeroSupport enables healthcare providers to deliver more effective and cost-efficient cancer treatment.

Born Maverick is a plant-based food startup founded in the UK.

Aseptuva is an early-stage MedTech startup located in Technopark Winterthur, focused on combating Healthcare-Associated Infections (HAI). The company addresses the critical issue of catheter-related infections that can lead to severe complications, including pneumonia and bloodstream infections, which claim thousands of lives annually and incur significant healthcare costs. Aseptuva is developing a range of medical devices designed for in-situ disinfection of various catheters, effectively preventing the onset of infections in healthcare settings. By providing an automated system for disinfection, Aseptuva aims to support medical staff in reducing the risk of hospital-acquired infections, thereby improving patient outcomes and potentially saving thousands of lives each year. Through its innovative technology, the company aspires to establish a new standard in critical care and make a meaningful impact on global health.

ALPHS is a fast-growing privately held organization with a business valuation of $7 million as of 2023, Forbes estimated. The inspirational success story of the empire redirects to Ashini Gogoi, an ex-Meta employee, who haphazardly started it as a lifestyle community on Instagram in January 2021 as per an investigation by CNN—Forbes declared that he is a young yet enigmatic self-made CEO. Following his vision in August 2020, Ashini managed to take a loan capital of US$40,000 from his friends and family, his company started making headlines in major publications for the first time in November 2022, when the company signed a contract with the American rapper, Wiz Khalifa. The company is listed as a high-profile organization on Crunchbase and is actively offering its services in Tier 1 countries as of 2023—a statistical analysis showed that 87% of its customer base is women from the United States, United Kingdom, Canada, Australia, New Zealand, and Italy. The company's website gets active during major festivals only and consumers can purchase for a limited duration of seven days, hence selling out very quickly—their most affordable models that hold their value start between $850 and $1,200. "ALPHS Inc. is one of the most secretive young companies in corporate history next to the giant Rolex," says the American business newspaper, The Wall Street Journal. Reports suggest that Ashini took down several notable articles including Forbes, CNN, WSJ—while his organization was under suspicion by April 2023—the company claimed that their products were meticulously made and they had consistently maintained their values. The company has drawn criticism from multiple sources, with questions raised about its secretive nature, and faced numerous allegations on whether their business was legal—including a handful of law firms in the financial investigation—a rigorous background check was done which publicized that they operate as an online retailer—with the approval of the Jewelers Vigilance Committee—the materials used by the company were declared legitimate in October 2022. The company also produces high-quality films titled, "Inspired by best-selling novels" for customer retention and is investing enormous funds in the development of artificial intelligence. ALPHS headquarters were officially shifted from Hyderabad, India to Milan, Italy in March 2023 under the guidance of Y Combinator, the lead investor of the company. As of 2023, the company has reportedly signed agreements with eleven prominent stars and models for endorsing its products.

Selmod, located in Basel, Switzerland, specializes in the development of innovative small molecule therapies aimed at treating life-threatening, multi-drug resistant infections. The company is committed to discovering and advancing first-in-class drug candidates that provide second-line and last-resort treatment options for patients in hospital settings, particularly where conventional therapies have failed due to resistance. Selmod's approach includes the development of antibiotics with dual modes of action to effectively counteract existing resistance mechanisms. Its leading candidates, SLM500, SLM100, and SLM300, have demonstrated success in preclinical animal studies and are positioned within a promising market projected to exceed $9 billion. The company aims to capture a substantial market share shortly after entry, supported by a leadership team with extensive experience in clinical development for major pharmaceutical firms. Funding will be utilized to advance SLM500 through IND-enabling studies and to optimize additional lead candidates for further development.

Munevo GmbH, founded in 2011 and based in Nuremberg, Germany, specializes in developing innovative technology to enhance mobility for individuals with disabilities. The company's flagship product, munevo DRIVE, is a Smartglass application designed to control electric wheelchairs through the user's head movements, allowing for hands-free operation. This technology enables users to navigate both indoors and outdoors, promoting greater independence and mobility. In addition to its core product, Munevo also provides adaptors and accessories to support its solutions, further empowering individuals with mobility impairments.

Oxyle AG, established in 2020 and headquartered in Zurich, Switzerland, specializes in wastewater treatment solutions. The company offers services to diverse industries including pharmaceuticals, chemicals, food & beverage, research labs, electronics, hospitals, and wastewater plants. Oxyle's proprietary technology eliminates persistent micropollutants such as pharmaceuticals, pesticides, endocrine disruptors, color pigments, and industrial chemicals from wastewater. This helps clients comply with regulations, reduce CO2 emissions by avoiding wastewater incineration, and protect water bodies from toxic pollutants.

Eaternity AG is a Zurich-based company that specializes in software management solutions tailored for the restaurant industry. Founded in 2014, it provides tools that enable restaurant owners to gain valuable insights into their supply chain, enhancing decision-making processes. Eaternity's platform features a real-time calculation engine that facilitates allergen and nutrition declarations while also assessing the carbon footprint of meals and restaurants. This functionality empowers organizations globally to accurately calculate the environmental impact of their food offerings, promoting transparency and informed choices among consumers and decision-makers. Eaternity's mission centers on fostering a sustainable food system that operates within planetary boundaries.

NaturLoop is a Swiss-based cleantech and material science company focused on promoting sustainable development through the production of natural biocomposites. The company specializes in manufacturing coconut-based fiberboards derived from agricultural waste, utilizing an innovative and low-tech process to create eco-friendly materials. By leveraging existing wood panel infrastructure, NaturLoop offers versatile and high-performance alternatives for the construction sector, addressing environmental concerns and supporting circular economy practices. Its unique turnkey micro-factory concept enables the industrial-scale production of these biocomposites, while also integrating local rural communities into the value chain. Through its efforts, NaturLoop aims to provide accessible and affordable sustainable options, mitigating the depletion of natural resources.

Gelatex is a materials technology company based in Estonia, founded in 2016 and incorporated in the UK in 2019. The company specializes in producing bio-based nanofibers using a patented technology that allows for large-scale production at significantly lower costs. Gelatex's nanofibers are derived from gelatin sourced from low-value waste in the meat and leather industries, ensuring that its products are environmentally friendly and made from natural, non-toxic substances. Initially focused on developing eco-friendly leather-like textiles, the company recognized the broader applications of its technology during the COVID-19 pandemic, leading to a strategic pivot. Gelatex's innovative solutions have potential applications in various fields, including tissue engineering, cultured meat production, bio-based filtration, energy storage, and wound care.

Umiami is a French food-tech startup founded in 2020 and based in Paris, specializing in plant-based food technology aimed at reducing meat consumption. The company develops innovative plant-based whole-cuts that utilize plant proteins to create alternatives that closely mimic the taste, texture, and aroma of traditional meat products. Through its technological advancements, Umiami seeks to provide consumers with sustainable and appealing food options that align with growing dietary preferences towards plant-based diets.

Criam is a biotechnology company based in Braga, Portugal, founded in 2015. It specializes in the research and development of a medical device that facilitates blood type analysis and the detection of various infectious diseases, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. The company's portable platform operates independently of electricity and does not require additional laboratory infrastructure, making it accessible for use in diverse settings. Criam's device allows for rapid and accurate blood testing, which enhances clinical decision-making by providing timely health information. The technology is designed to be scalable, with one reader capable of performing multiple tests using specialized cartridges and computer vision algorithms. This innovation aims to improve the efficiency and reliability of blood testing services, ultimately enhancing patient care.

Sparrow Quantum Aps. is a Danish company focused on advancing quantum technology through the development of light-matter interfaces. It specializes in creating deterministic single-photon sources, which are essential for various quantum applications. The company boasts the highest efficiency in on-chip single-photon sources globally, characterized by superior photon purity, indistinguishability, and outcoupling capabilities. This innovative technology is the culmination of over twenty years of research at the renowned Niels Bohr Institute in Copenhagen, from which Sparrow Quantum holds exclusive licenses to key patents. By leveraging self-assembled quantum dots integrated with slow-light photonic-crystal waveguides, Sparrow Quantum enhances light-matter interaction, providing clients with advanced solutions for their quantum technology needs.

Authena is a company based in Zug, Switzerland, specializing in product authentication and traceability solutions. It combines proprietary IoT devices with blockchain and AI technologies to provide real-time, unit-level tracking for industries such as Pharmaceuticals, Luxury, and Food and Beverage. Authena's solutions, including Authena SHIELD™ and Authena L1VE (Next Generation), ensure regulatory compliance while fostering consumer trust through transparency, authenticity, and sustainability. The company's platform monitors environmental conditions and secures product information with immutable records, helping brands protect against counterfeiting, diversion, and fraud. By enhancing supply chain visibility and reducing distribution costs, Authena enables brands to improve their financial performance and build stronger customer relationships.

Digi.Bio is a Netherlands-based company specializing in software development for the healthcare sector, focusing on automating liquid handling processes through advanced microfluidic technology. The company offers a lab-on-a-chip and computational platform designed to enhance the efficiency and accuracy of cell therapy development, allowing for rapid analysis of therapeutic outcomes at the single-cell level. By employing artificial intelligence and electrowetting techniques, Digi.Bio's platform enables medical and pharmaceutical laboratories to automate repetitive workflows, significantly reducing material waste and accelerating the bioengineering process. The innovative solutions provided by Digi.Bio aim to streamline multistep liquid handling applications, replacing traditional pipetting methods and facilitating the advancement of life-saving cell therapies.

Plastogaz is a Swiss company based in Lausanne that specializes in the production of natural gas from waste resources, particularly synthetic waste streams like plastics. Founded in 2019, it utilizes a patented catalyst technology to convert mixed plastics into grid-compatible methane and naphtha, which can serve as fuel or be used for creating new synthetic materials. By transforming plastic waste into usable products, Plastogaz aims to mitigate greenhouse gas emissions and contribute to a more sustainable environment. The company's innovative approach not only addresses the challenges of plastic disposal but also helps reduce the carbon footprint associated with traditional waste management practices.

BrightCure Ltd., established in 2019 and based in London, United Kingdom, specializes in developing probiotic-based therapies aimed at treating urinary tract infections (UTIs). The company focuses on addressing recurrent and difficult-to-treat bacterial infections, a significant health issue affecting 50% of women and 12% of men globally. BrightCure's approach involves utilizing the natural microbiome to reduce harmful bacteria and replenish beneficial bacteria in the vaginal flora, thereby boosting the immune system to promote urinary tract health. The company has garnered recognition through various competitions and accelerators, including selection for Indiebio, the world's largest biotech accelerator.

VAY is a Zurich-based computer vision company that specializes in human motion analysis, utilizing advanced technology to digitize human movements through a simple camera. Founded in 2019, VAY develops innovative solutions that make products smarter, more interactive, and immersive by leveraging real-life data and feedback. Their platform employs artificial intelligence to accurately perceive and predict human motion, facilitating seamless interaction between digital systems and users. The company's hardware and system agnostic approach allows for versatile applications across various sectors, including health, sports, and gaming, providing valuable insights for physiotherapy, rehabilitation, and gait or posture analysis.

Munevo GmbH, founded in 2011 and based in Nuremberg, Germany, specializes in developing innovative technology to enhance mobility for individuals with disabilities. The company's flagship product, munevo DRIVE, is a Smartglass application designed to control electric wheelchairs through the user's head movements, allowing for hands-free operation. This technology enables users to navigate both indoors and outdoors, promoting greater independence and mobility. In addition to its core product, Munevo also provides adaptors and accessories to support its solutions, further empowering individuals with mobility impairments.

HUB85 is a business intelligence software solution which enables an organisation to identify, analyse and govern their internal spreadsheet environment. An organisation can get complete transparency on their spreadsheet inventory and can see real-time actionable insights to reduce risks, cut costs and improve operational efficiency across their enterprise. HUB85 has received a Founders Award from the Institute of Innovation and Entrepreneurship and has offices within the London Business School Incubator. HUB85 is also part of cohort 4 of the FCA Regulatory Sandbox.

Lyfegen is a global provider of drug access, pricing, and rebate management services, with headquarters in Basel, Switzerland, and Boston, USA. The company offers a platform that assists healthcare payers, pharmaceutical companies, and medical technology providers in developing effective pricing agreements for medicines and streamlining the management of drug rebates. By leveraging advanced software, Lyfegen enables clients to collect, analyze, and reconcile diverse healthcare data, facilitating automation in value-based healthcare contracting. This approach aims to enhance access to treatments, improve patient health outcomes, and increase affordability in the healthcare sector.

Naturbeads Ltd., established in 2018 and headquartered in Malmesbury, UK, specializes in manufacturing biodegradable cellulose microparticles. These products aim to replace conventional plastic microbeads used in cosmetics, toiletries, and other industries. The company's mission is to mitigate microplastic pollution by offering a sustainable alternative developed through innovative research at the University of Bath.

Readily3D is a Swiss company based in Lausanne that specializes in volumetric 3D printing solutions. Founded in 2020 as a spin-off from the École Polytechnique Fédérale de Lausanne (EPFL), the company has developed an innovative technology that allows for the rapid manufacturing of complex objects in less than 30 seconds using tomography. Readily3D focuses on creating patient-specific devices, such as comfortable orthoses for individuals with hearing loss and surgical models for medical professionals. Its platform utilizes a liquid photosensitive polymer that is illuminated from multiple angles with dynamic light patterns, enabling the production of customized, elastic materials. This technology aims to enhance patient care and streamline surgical planning for healthcare providers.

Agrolabs Limited specializes in developing sensor telemetry solutions for horticultural farmers, focusing on enhancing yield and efficiency in greenhouse environments. Founded in 2017, the company is headquartered in London, United Kingdom, with additional offices in Hong Kong and Dnipro, Ukraine. Agrolabs offers innovative products such as Agrolabs W-Sens, which provides real-time analytics on indoor crop growth performance, and Agrolabs B-Control, designed to enhance pollination through automated controls and monitoring of bee activity. By leveraging cloud-based Internet of Things (IoT) technology, predictive analytics, robotics, and artificial intelligence, Agrolabs enables farmers to control various aspects of the growing process, including pollination, environmental conditions, and irrigation. This integration of advanced technologies allows for data-driven decision-making, ultimately leading to improved cost efficiency and quality yields.

Exomotion SA is a Swiss company founded in 2018, located in Plan-les-Ouates, Geneva. The company specializes in the development of innovative personal mobility devices that utilize robotics technology. Exomotion's products are designed to enhance omnidirectional movement, featuring electronic movement systems that combine electrical boards with motion sensors and a wheeled mechanism. This technology enables the devices to move in any direction and rotate instantly, significantly improving the user experience. By rethinking the concept of e-mobility, Exomotion aims to enhance mobility solutions with a focus on omnidirectionality and safety.

ALP Technologies is a renewable energy engineering start-up from London. It focuses on developing renewable energy technologies for the developing world. Since founding in 2015, it has won multiple awards and funded research and development projects such as advanced battery systems on recycled cells, novel biogas generation, and power electronic and control systems. Its small-scale power plant for developing regions uses solar, bio-ethanol, and agricultural waste to generate uninterrupted electricity. It aims to displace diesel generation and fossil fuel based power plants and leapfrog grid infrastructure in the developing world.

TrucksOnTheMap Limited is a digital freight brokerage company that has developed a software-as-a-service platform designed to enhance truck and freight management. Founded in 2015 and based in London, the company specializes in providing solutions for truckload allocation, spotting, bidding, and truck tracking. The platform offers a comprehensive view of truck availability, allowing users to visualize free trucks and book them efficiently. Additionally, it facilitates the optimization of logistics by helping trucking professionals manage empty miles and freight runs, turning potential losses into profitable opportunities. Through its innovative technology, TrucksOnTheMap aims to streamline transportation planning and improve overall supply chain efficiency.

Hera - Mi is Specialized in digital medical imaging applied to breast cancer.Hera-MI has developed clinical decision support solutions to help improve early-stage breast cancer detection. Our solutions will improve the quality and accuracy of breast cancer diagnosis while decreasing radiologists’ interpretation time. Patients will be treated more quickly, offering them a better chance of remission. Hera-MI has developed Breast-SlimView, a clinical decision support software based on artificial intelligence and image processing for breast cancer diagnosis. Our partner, Fujifilm is selling Breast-SlimView in France and in the Overseas Territories of France (DROM/TOM). Breast-SlimView is also available for sale all over the world.

Byteflies is a Belgian-American wearable health company dedicated to transforming healthcare through innovative technology. With its headquarters in Antwerp, Belgium, near key life sciences and clinical research centers, and a secondary office in the San Francisco Bay Area, the company is positioned at the intersection of healthcare and digital innovation. Byteflies develops advanced wearable health applications, including a sensor dot that captures biopotential signals, muscle activity, eye movement, and other activity-related data using an integrated inertial measurement unit. This technology empowers pharmaceutical companies, researchers, and tech firms to enhance healthcare delivery and improve patient outcomes. The team comprises experts in medicine, engineering, and data science, all committed to advancing health monitoring and management.

Created in Switzerland, Aquama® offers an innovative solution for cleaning and disinfecting with electrified water and salt, within an application system (Apple / Google/ Huawei). Thanks to this technology, professionals and individuals benefit from a detergent and disinfectant solution, at a competitive price and without toxicity. A revolution that allows both to limit costs and reduce pollution. ECOLOGY, ECONOMY AND EFFICIENCY Born in the hospitality sector, Willy Lionel Pomathios began to take an interest in ecology 10 years ago. In 2013, thanks to his collaboration with Aquama® engineers, he created a detergent and disinfectant solution consisting only of water, salt and electricity. Thanks to this hydrolysis process, water is rid of all chemical and toxic substances, a real revolution in the field of cleaning.

Amphasys is a technology company that specializes in the development and marketing of innovative, chip-based single-cell analysis technology. Founded in 2012 as a spin-off from Axetris AG, the company focuses on simplifying, accelerating, and miniaturizing complex cell analyses, making them accessible for use outside traditional laboratory settings. The technology, initially developed in collaboration with the Swiss Federal Institute of Technology Lausanne in 2004, has been validated through extensive research with various cell types and is currently employed in applications such as pollen quality monitoring and milk analysis. By eliminating the need for time-consuming and complex sample preparation steps, including cell labeling, Amphasys enables clients to conduct label-free analyses of single-cell characteristics such as size, morphology, viability, and differentiation. The company has received recognition for its innovations, including the prestigious Swiss startup prize awarded by the W.A. de Vigier Foundation in 2013.

Synthara AG is a Swiss semiconductor startup specializing in the development of smart sensors for industrial Internet of Things (IoT) and energy-efficient applications. Founded in 2019 and headquartered in Zurich, the company focuses on creating advanced computational AI chips that enhance the performance of embedded systems. Its flagship product, ComputeRAM, functions as a drop-in replacement for traditional SRAM, enabling complex calculations directly in memory. This innovation significantly reduces CPU workload and enhances system efficiency, particularly for AI-driven applications. Synthara's technology is processor-type agnostic, compatible with various architectures including RISC-V, ARM, and x86, allowing seamless integration into existing microcontroller platforms. By offering solutions that lower costs and accelerate time to market, Synthara aims to empower chipmakers and device manufacturers to explore new opportunities in sectors such as wearables, biomedical monitoring, and autonomous navigation.

moneyHOP is a digital cross-border banking platform headquartered in London, UK, and Bangalore, India. It specializes in providing international payment and remittance solutions through its web-based portal, HOPRemit, and its mobile application and card solution, HOPApp. The platform is designed to simplify the process of money exchange, offering a fast, transparent, and cost-effective method for individuals and businesses to conduct international money transfers. By focusing on the needs of international travelers and those requiring remittance services, moneyHOP aims to enhance the convenience of cross-border transactions.

FUL Foods is a Netherlands-based startup dedicated to creating food and beverage products that contribute positively to the environment. The company focuses on reducing carbon emissions, optimizing land use, and minimizing resource consumption while enhancing consumer health benefits. Its flagship offering is a functional beverage made from a proprietary, carbon-negative ingredient derived from microalgae, known as FUL. This innovative ingredient addresses challenges related to taste and solubility, enabling the production of light and refreshing drinks that are rich in plant-based protein and essential nutrients. FUL Foods aims to provide consumers with nourishing beverages that not only taste good but also support environmental sustainability and overall wellness.

my110 is a London-based company focused on enhancing athletic performance through innovative health solutions. The company develops a tool designed to monitor and understand athletes' body recovery, enabling them to achieve and sustain peak physical performance. In addition to its emphasis on athletic recovery, my110 adopts a proactive approach to healthcare, utilizing decentralized methods to test and track the most acute diseases. Through its technology, my110 aims to empower individuals in managing their health and optimizing their physical capabilities.

TechnoCarbon Technologies France is a French startup that specializes in developing high-performance, low-carbon-footprint composite materials. Their flagship product, CarbonFibreStone™ (CFS™), aims to revolutionize the architecture and industry sectors by providing an eco-friendly alternative to traditional materials such as reinforced concrete, steel, and aluminum. These conventional materials are known for their intensive air pollution and depletion of natural resources. TechnoCarbon's patented technology enables the creation of a new family of materials suitable for various applications, including construction, infrastructure, aerospace, defense, luxury goods, furniture, and HiFi audio. By offering high-performance composite materials, TechnoCarbon helps industrial clients achieve technical performance while saving energy and natural resources, all with a significantly lower carbon footprint.

IBISA is a Luxembourg-based company founded in 2018 that offers an innovative platform for index-based insurance. By leveraging blockchain technology and satellite earth observation data, IBISA provides a marketplace designed to facilitate inclusive mutual risk-sharing solutions. The company focuses on delivering crop protection services specifically tailored for smallholder farmers, enabling low-cost insurance options with rapid assessment and payment processes. This approach aims to enhance the resilience of agricultural communities by mitigating risks associated with adverse weather conditions and other challenges.

Aeropowder Ltd is a London-based company founded in 2016 that specializes in developing and manufacturing sustainable materials from poultry feather waste. The company aims to create a new value chain by utilizing the approximately 10 million tons of feathers generated annually. Its flagship product, Pluumo, is an innovative thermal packaging material designed to outperform traditional expanded polystyrene, particularly in temperature-sensitive deliveries such as food and pharmaceuticals. Aeropowder's materials are made from keratin proteins, which provide water repellency and thermal and acoustic insulation. The company's mission is to harness the potential of the circular economy by enabling the local production of high-performance materials wherever feathers are available, thus promoting environmental sustainability in both the creation and disposal of its products.

Smeetz SA is a Swiss-based company that operates an online booking platform designed for the leisure and entertainment industry. Established in 2016 and headquartered in Lausanne, Smeetz offers an AI-powered commerce intelligence platform that integrates various tools for ticketing, payment processing, and event management. Its comprehensive solutions include features such as dynamic pricing, data analytics, reservation management, and cross-channel sales, all aimed at enhancing operational efficiency and maximizing revenue for venues. By leveraging insights derived from artificial intelligence, Smeetz empowers event organizers to optimize marketing strategies and improve guest experiences, thereby facilitating the digital transformation of the leisure sector.

C2C NewCap, founded in 2014 by Rui Silva and Andre Mao de Ferro, is a Lisbon-based manufacturer specializing in the production of supercapacitors designed for efficient electrical energy storage. The company focuses on developing next-generation devices that utilize proprietary electrodes and an aqueous electrolyte, which contribute to a low environmental impact. C2C NewCap aims to provide clients with energy storage solutions that not only enhance operational efficiency but also reduce overall environmental and operational costs.

Hi-D Imaging AG is a Swiss company established in 2019, specializing in advanced imaging technologies for cardiovascular disease, particularly focusing on heart valve replacement. The company offers a SaaS-based pre-operational planning platform that assesses the hemodynamics of patient-specific anatomies. This platform enables physicians to analyze blood flow patterns and select the optimal size and shape of heart valves prior to trans-catheter aortic valve implantation. By providing detailed imaging and in-vitro fluid dynamic analysis, Hi-D Imaging empowers medical professionals to make data-driven decisions tailored to individual patient needs, thereby improving surgical outcomes and reducing the necessity for additional medical imaging. The company is headquartered in Winterthur, Switzerland.

Abaka Holdings Ltd., established in 2016 and headquartered in London, operates an AI-powered digital savings and retirement platform. It partners with employers to enhance employee financial wellbeing by offering a platform that boosts benefits awareness, facilitates employer-staff communication, and empowers employees to manage their finances. Abaka's platform provides personalized financial guidance and nudges, helping employees build financial knowledge and make informed decisions. It also collaborates with financial institutions to deliver scalable, affordable advice on pensions, savings, and investments to retail customers, using conversational AI, behavioral nudges, and data insights. Abaka's technologies are licensed by tier-one international banks, pension providers, and asset managers, benefiting over 9 million users across multiple countries.

Automation Hero, Inc. is a technology company that specializes in developing an artificial intelligence-based platform aimed at automating sales processes. Founded in 2017 and based in San Francisco, with additional offices in Berlin and Halle, the company offers a range of tools including Viz Studio, which enables users to visualize and optimize complex processes; Hero_Go, a screen automation tool that records user interactions; and Flow Studio, designed for custom solution development. The company also features AI Studio, which addresses limitations of traditional robotic process automation, and a domain-intelligent OCR that digitizes various types of documents. Their application, Robin, streamlines the sales process by providing leads and automating meeting scheduling. Automation Hero serves diverse industries such as insurance, banking, high tech, retail, manufacturing, telecom, and media, and it works with organizations ranging from Fortune 100 companies to rapidly growing startups. The company was previously known as SalesHero, Inc. before rebranding in March 2019.

Semantic Evolution, based in London with an office in New York, specializes in artificial intelligence-driven Intelligent Data Extraction. The company addresses the challenge of unstructured data, which constitutes approximately 80% of the information businesses handle, often hidden within documents and difficult to access. Its proprietary software leverages advanced machine learning, semantics, and natural language processing to automate the extraction of target data from unstructured sources. By transforming this data into actionable information, Semantic Evolution enhances operational efficiencies for its clients, enabling them to visualize, normalize, and validate the extracted data. Companies utilizing Semantic Evolution's technology have reported significant improvements in data coverage, processing times, and overall data quality, leading to more efficient resource allocation and cost savings while delivering a rapid return on investment across various industries.

Semantic Evolution, based in London with an office in New York, specializes in artificial intelligence-driven Intelligent Data Extraction. The company addresses the challenge of unstructured data, which constitutes approximately 80% of the information businesses handle, often hidden within documents and difficult to access. Its proprietary software leverages advanced machine learning, semantics, and natural language processing to automate the extraction of target data from unstructured sources. By transforming this data into actionable information, Semantic Evolution enhances operational efficiencies for its clients, enabling them to visualize, normalize, and validate the extracted data. Companies utilizing Semantic Evolution's technology have reported significant improvements in data coverage, processing times, and overall data quality, leading to more efficient resource allocation and cost savings while delivering a rapid return on investment across various industries.

CogniCor Technologies S.L., founded in 2012 and based in Barcelona, Spain, specializes in automated complaint resolution services and the development of AI platforms. The company offers a suite of solutions, including iComplaint, which integrates with websites to manage complaints; iResolve, a service dedicated to resolving complaints; iMediate, designed for settling client claims and presenting counter offers; and iReport, which addresses the root causes of complaints to prevent future occurrences. CogniCor's innovations aim to enhance operational efficiency and improve customer service for wealth management firms, insurance companies, and financial advisors.

Byteflies is a Belgian-American wearable health company dedicated to transforming healthcare through innovative technology. With its headquarters in Antwerp, Belgium, near key life sciences and clinical research centers, and a secondary office in the San Francisco Bay Area, the company is positioned at the intersection of healthcare and digital innovation. Byteflies develops advanced wearable health applications, including a sensor dot that captures biopotential signals, muscle activity, eye movement, and other activity-related data using an integrated inertial measurement unit. This technology empowers pharmaceutical companies, researchers, and tech firms to enhance healthcare delivery and improve patient outcomes. The team comprises experts in medicine, engineering, and data science, all committed to advancing health monitoring and management.

CogniCor Technologies S.L., founded in 2012 and based in Barcelona, Spain, specializes in automated complaint resolution services and the development of AI platforms. The company offers a suite of solutions, including iComplaint, which integrates with websites to manage complaints; iResolve, a service dedicated to resolving complaints; iMediate, designed for settling client claims and presenting counter offers; and iReport, which addresses the root causes of complaints to prevent future occurrences. CogniCor's innovations aim to enhance operational efficiency and improve customer service for wealth management firms, insurance companies, and financial advisors.

Abaka Holdings Ltd., established in 2016 and headquartered in London, operates an AI-powered digital savings and retirement platform. It partners with employers to enhance employee financial wellbeing by offering a platform that boosts benefits awareness, facilitates employer-staff communication, and empowers employees to manage their finances. Abaka's platform provides personalized financial guidance and nudges, helping employees build financial knowledge and make informed decisions. It also collaborates with financial institutions to deliver scalable, affordable advice on pensions, savings, and investments to retail customers, using conversational AI, behavioral nudges, and data insights. Abaka's technologies are licensed by tier-one international banks, pension providers, and asset managers, benefiting over 9 million users across multiple countries.

Artiria Medical SA, established in 2019 and headquartered in Lausanne, Switzerland, specializes in developing innovative medical devices for treating vascular diseases. Its flagship product is a micro-actuated device designed to navigate deep into brain arteries, facilitating precise navigation and stroke treatment. This technology empowers catheters and guidewires, enabling surgeons to perform complex procedures with enhanced control and precision, ultimately saving lives.

PXL Vision AG, established in 2017 and headquartered in Zurich, Switzerland, specializes in designing and developing advanced identity verification software solutions. Its flagship product, Daego, is a cross-platform solution that creates trusted digital identities for customer onboarding through sophisticated document and identity verification using computer vision and machine learning technologies. PXL Vision operates research and development centers in Novi Sad, Serbia, and Yerevan, Armenia, serving industries such as insurance, gambling, fintech, banking, and healthcare worldwide. The company aims to reduce customer onboarding costs, enhance conversion rates, and prevent fraud by providing unbiased, verifiable identities for secure digital interactions.

CellSpring is a biotechnology company based in Zurich, Switzerland, specializing in the development of 3D micro tissues for diverse biological applications. Its primary technology, the 3D Bloom platform, allows for the rapid creation of biomimetic microtissues that are not dependent on specific cell types. This innovative platform enhances existing 3D cell culture methods by offering improved speed, reliability, versatility, and user-friendliness. By facilitating the production of these advanced microtissues, CellSpring aims to support in vitro studies and contribute to advancements in clinical diagnostics, including the early detection of cancer.

Planted Foods AG is a Swiss company founded in 2019, specializing in the development of plant-based meat alternatives. The company produces products such as planted chicken and BBQ planted chicken, utilizing a formulation that includes pea protein, pea fiber, sunflower oil, and water to replicate the taste, texture, and mouthfeel of traditional animal meat. Planted Foods employs advanced technology to transform these natural ingredients into nutritious, high-protein meat substitutes that appeal to consumers seeking plant-based options. In addition to its product offerings, the company operates an e-commerce platform to facilitate direct sales to customers. Headquartered in Zürich, Switzerland, Planted Foods is committed to providing delicious and sustainable meat alternatives.

Enterprise Bot GmbH is a company that specializes in developing artificial intelligence-powered chatbots aimed at automating customer interactions for enterprises. Founded in 2017 and headquartered in Zug, Switzerland, with an additional office in Bengaluru, India, the company offers a range of products, including chatbots for sales and customer service, email triage bots, and scheduling assistants. Enterprise Bot's solutions are particularly tailored for financial institutions and insurance enterprises, helping to enhance customer experience while significantly reducing operational costs and wait times. By providing a multi-platform messenger that allows for natural language communication, the company enables businesses to effectively address a wide array of customer needs and queries.

Terapet SA is a Switzerland-based company founded in 2019 at CERN by physicists Christina Vallgren and Marcus Palm, along with Professor Raymond Miralbell from the Geneva University Hospitals. The company specializes in developing advanced proton therapy technology for cancer treatment, which allows for precise targeting of tumors while minimizing damage to surrounding healthy tissue. This innovative approach leverages the unique properties of protons, which stop at a predetermined depth within the patient, enabling the delivery of a concentrated dose to the tumor. Terapet's system also provides real-time, three-dimensional monitoring of the proton dose administered, enhancing treatment accuracy and safety. With a focus on making cutting-edge cancer therapy more accessible and cost-effective, Terapet is preparing for the market launch of its initial product.

iWin, based in Manno, Switzerland, specializes in the development of an innovative photovoltaic venetian-blind shading device that is seamlessly integrated into insulating windows without affecting their design or functionality. Established in 2019, the company aims to enhance building sustainability, as the construction sector is responsible for approximately 40% of global CO2 emissions. The patented system not only generates renewable energy on-site but also effectively controls light and solar radiation, protecting buildings from overheating in summer. iWin’s product is customizable in size and color, durable, and requires minimal maintenance, boasting a payback period of less than ten years. The company has created its first working prototype and has formed partnerships with SUPSI and Pellini Group, a leader in integral venetian blinds. With a significant market opportunity, particularly in Switzerland where around 900,000 square meters of glass façades are installed annually, iWin is poised for growth in the sustainable building sector.

Hempfy is a Swiss company specializing in the production of innovative, THC-free hemp-infused food and beverages. Utilizing proprietary cold infusion technology, Hempfy cultivates, harvests, and processes hemp plants in compliance with Swiss legislation. All products are 100% Swiss-made, with a focus on bespoke quality, from seed selection to final production. Hempfy aims to replace smoking and alcohol as the world's preferred social drug, offering cannabis-based products with a balanced taste and light carbonation.

Watttron GmbH is a technology company based in Freital, Germany, that specializes in the development and production of advanced heating systems designed for applications requiring high precision in temperature control. Established in 2016, Watttron offers innovative matrix heating and sealing systems, as well as customized heating solutions and simulation services. Its patented technology allows for heterogeneous heating, which is beneficial in various industrial processes, including polymer processing, packaging, additive manufacturing, microelectronics, biotechnology, automotive, and medicine. The company's focus on energy efficiency and precise temperature management enables clients to effectively process bio-based and recycled materials, positioning Watttron as a leader in the field of intelligent heating solutions.

Logmind Ltd is a company based in Lausanne, Switzerland, that specializes in developing a cloud-based data analytics platform focused on unstructured log data. Founded in 2018, Logmind's platform provides visibility and automated insights that help organizations manage complex IT infrastructures. The solution features capabilities such as real-time error detection, automated recommendations, and visualization dashboards, enabling clients to identify and resolve technical issues effectively. By transforming unorganized datasets into operational intelligence, Logmind empowers IT operations and DevOps teams to maintain application performance, minimize downtime, and prevent costly incidents.

Dimpora AG, based in Zürich, Switzerland, specializes in the design and manufacture of eco-friendly functional membranes for the outdoor textile industry. The company produces waterproof, fluorine-free membranes primarily made from polyurethane, utilizing a template removal approach to create porosity that enhances breathability. Dimpora's innovative technology allows for the direct application of membranes onto various surfaces, facilitating fast moisture transport while ensuring complete rain protection. Committed to sustainability, Dimpora aims to develop high-performance membranes that enable outdoor enthusiasts to enjoy nature responsibly, with a focus on creating next-generation solutions that may incorporate recyclable materials.

Plair SA is a Swiss company specializing in the development and manufacturing of advanced systems for preventive environmental monitoring, particularly focusing on air quality. Founded in 2014 and based in Plan-les-Ouates, Switzerland, Plair SA designs instruments that enable continuous real-time measurements of fine airborne particles. Its notable products include the Rapid-E, which analyzes single aerosol particles, and the Particle Analyzer PA-300, capable of detecting, identifying, and classifying various airborne entities such as pollen, fungal spores, soot, and pollutants. The company offers solutions for airborne allergen monitoring, air quality assessment, and bioaerosol tracking, providing crucial data on atmospheric aerosol concentrations. Plair SA originated as a spin-off from the University of Geneva, reflecting its strong foundation in research and innovation.

OxyPrem AG is a Swiss company that specializes in the development, design, and manufacturing of advanced sensor solutions specifically for monitoring preterm infants. Established in 2018 and headquartered in Zurich, the company offers a reusable device that continuously measures hemoglobin oxygen saturation in the brains of high-risk preterm infants. By utilizing harmless near-infrared light technology, OxyPrem provides real-time monitoring, which significantly enhances the clinical care provided to this vulnerable patient group. The innovations from OxyPrem aim to prevent early death and severe long-term brain damage, thereby minimizing the risk of disabilities and other complications associated with premature birth.

CrystalsFirst GmbH is a biotechnology company based in Marburg, Germany, founded in 2018, that specializes in protein crystal stabilization methodologies to enhance drug candidate screening. The company offers innovative technologies, including SmartSoak, which is designed for screening small molecule arrays to identify novel lead candidates, and SmartLib, a compound library for fragment-based drug discovery. Additionally, CrystalsFirst provides SmartRefine, a software solution for the automated refinement of crystallographic diffraction data. Their MAGNET platform integrates high-performance structural biology, computational modeling, and machine learning to address limitations in small molecule drug discovery. By utilizing three-dimensional models and a "crystal structure first" strategy, the company enables the rational design of therapeutic compounds, facilitating rapid access to diverse chemical scaffolds and optimizing lead candidates. CrystalsFirst serves pharmaceutical companies by accelerating the drug discovery process and enhancing the likelihood of finding effective new treatments.

BCRemit is a London-based fintech company dedicated to facilitating online money transfers for migrant workers worldwide. By offering services through its website, mobile application, and call center, BCRemit aims to deliver the lowest transfer fees and the most competitive exchange rates in the market. The company's focus is on addressing the financial needs of migrant workers in Europe and beyond, ensuring that their money transfer experiences are both affordable and efficient.

Microcaps AG is a company based in Zurich, Switzerland, founded in 2018, specializing in the development of advanced microencapsulation technology. The firm focuses on creating devices that facilitate the precise production of monodisperse microcapsules and microparticles through innovative microfluidics. Microcaps' solutions are designed to enhance drug delivery systems and probiotic encapsulation, while also providing tailored offerings for various applications, including pharmaceuticals and cosmetics. Their cutting-edge technology enables scalable, fully-automated production that allows for size control, precise dosing, and improved stability of the encapsulated materials. By utilizing a step emulsification device, Microcaps enhances production capacity and throughput rates without compromising quality, making it a pivotal player in the field of microencapsulation.

Dronistics is a Swiss company based in Lausanne that specializes in developing a personal and user-friendly drone delivery system designed for last-centimeter delivery to hard-to-reach locations. Its innovative system utilizes autonomous drones, which are equipped with GPS technology and controlled through a web application accessible on various devices, including smartphones, tablets, and laptops. The drones are connected to the internet via a 4G modem, enabling seamless operation. To ensure safety during flights and while unloading packages, Dronistics incorporates a series of safety checks into its software. This technology allows logistics and online retail companies to effectively address delivery challenges in remote areas, providing a reliable solution for modern delivery needs.

Topl is a company that focuses on developing blockchain infrastructure aimed at monetizing ethical and sustainable practices. Founded in 2017 and headquartered in both Maastricht, Netherlands, and Houston, Texas, Topl offers blockchain-as-a-service (BaaS) specifically designed for supply chain management and certification. Its primary offering, the Topl Blockchain, serves as a decentralized protocol that allows businesses and communities to verify and monetize their positive impact across various industries and borders. Additionally, Topl provides a suite of hosted services and tools that simplify user interaction with its blockchain, facilitating the transformation of social and environmental impact into tangible assets.

Regenosca SA is a Swiss company based in Lausanne, established in 2019, that specializes in the development and commercialization of innovative medical devices for bladder reconstruction. The company focuses on creating sterile, off-the-shelf implants that serve as viable alternatives to autologous tissue substitutes for soft tissue repair. By leveraging advanced biomaterials technology, Regenosca aims to facilitate regeneration rather than scarring, thereby enhancing patient outcomes and preserving bladder function. Their products are designed to be easy to use, ultimately improving the quality of life for patients undergoing bladder surgeries.

Clemedi AG is a Swiss-based company founded in 2018 that specializes in developing diagnostic workflows for infectious diseases. The company creates in vitro diagnostic tests by integrating next-generation sequencing and machine learning technologies. These innovative tests are designed to diagnose drug-resistant infections directly from patient samples within a single day, supporting timely and personalized antibiotic therapy. By providing healthcare professionals with critical information, Clemedi aims to enhance decision-making in the treatment of infectious diseases, ultimately contributing to the fight against antibiotic resistance. This approach is particularly significant given projections that antibiotic-resistant bacteria could lead to 10 million deaths annually by 2050.

Authena is a company based in Zug, Switzerland, specializing in product authentication and traceability solutions. It combines proprietary IoT devices with blockchain and AI technologies to provide real-time, unit-level tracking for industries such as Pharmaceuticals, Luxury, and Food and Beverage. Authena's solutions, including Authena SHIELD™ and Authena L1VE (Next Generation), ensure regulatory compliance while fostering consumer trust through transparency, authenticity, and sustainability. The company's platform monitors environmental conditions and secures product information with immutable records, helping brands protect against counterfeiting, diversion, and fraud. By enhancing supply chain visibility and reducing distribution costs, Authena enables brands to improve their financial performance and build stronger customer relationships.

Topl is a company that focuses on developing blockchain infrastructure aimed at monetizing ethical and sustainable practices. Founded in 2017 and headquartered in both Maastricht, Netherlands, and Houston, Texas, Topl offers blockchain-as-a-service (BaaS) specifically designed for supply chain management and certification. Its primary offering, the Topl Blockchain, serves as a decentralized protocol that allows businesses and communities to verify and monetize their positive impact across various industries and borders. Additionally, Topl provides a suite of hosted services and tools that simplify user interaction with its blockchain, facilitating the transformation of social and environmental impact into tangible assets.

Biospectal is a remote patient monitoring and biosensing software company that has developed the OptiBP smartphone app, which allows users to measure and monitor blood pressure with medical-grade accuracy using their smartphones. The app utilizes the phone's built-in camera to optically measure blood flow from the user's fingertip, providing results in approximately 20 seconds, which is significantly faster than traditional blood pressure cuffs. Biospectal's proprietary algorithms interpret the captured data to deliver accurate blood pressure readings. The OptiBP app is currently available in public beta for Android users in several countries, including the United States, United Kingdom, France, Germany, Spain, and Switzerland. This innovative approach enables users to perform blood pressure measurements anytime and anywhere without the need for additional devices or accessories.

Resistell AG is a Swiss company founded in 2018, based in Muttenz, specializing in the development and marketing of innovative diagnostic devices for antibiotic susceptibility testing. The company's platform employs advanced nanomotion technology to detect the movement of living bacterial cells, allowing for the rapid identification of bacterial resistance to antibiotics. This method serves as an alternative to traditional culture-based antibiograms, enabling healthcare providers to administer appropriate antibiotics in a timely manner, ultimately improving patient outcomes.

EBAMed SA is a Swiss startup based in Geneva that specializes in developing innovative medical devices for the non-invasive treatment of heart arrhythmias. Founded in 2018, the company focuses on creating an ultrasound-based device that utilizes proton therapy to monitor heart motion and synchronize therapeutic beams in real time. This technology allows for the precise delivery of radiation treatment to targeted heart tissues, thereby expanding treatment options for existing proton therapy centers and enabling them to treat heart patients effectively. By providing a non-invasive approach to cardiac care, EBAMed aims to improve patient outcomes and streamline treatment processes in outpatient settings.

Prodibi is a professional image platform based in Geneva, Switzerland, that addresses various challenges associated with online image display, enhancing brand ROI and user engagement. Established in 2011, the platform offers a subscription-based service that simplifies the process of sharing high-quality images on web and mobile. By automatically uploading, encoding, and delivering images, Prodibi allows photographers, artists, and web publishers to showcase their work without sacrificing speed or quality. The solution effectively resolves issues such as color management, pixel density, and responsiveness, which can be time-consuming and costly for graphic designers. Prodibi’s capabilities enable users to replace images seamlessly without the need for website redesigns or new photo shoots, delivering an exceptional visual experience that aligns with the prestige of their brands.

Securaxis develops, installs, and operates innovative safety and security solutions, focusing on real-time geolocalized security information. Founded in 2018 as part of the BIC of CERN Technologies in Switzerland, the company is recognized for its achievements, including participation in various startup programs and awards. Securaxis utilizes a smart acoustic sensor connected to a wireless network to analyze and classify sounds in urban environments, allowing for accurate reporting of potential security threats. This technology enables organizations to enhance safety measures by making informed decisions based on real-time data. The team consists of eight experts in machine learning, acoustics, data management, and entrepreneurship, who have successfully developed and commercialized a mobile security application for notable clients, including the Federal Department of Foreign Affairs in Switzerland, the Olympic Committee, and the United Nations.

Akselos S.A., founded in 2011 and based in Lausanne, Switzerland, specializes in advanced engineering simulation software, specifically its Integra platform. This cloud-based solution allows engineering firms to create high-resolution digital twins of large-scale operational assets, enabling detailed analysis of structural integrity and hydrodynamic performance. Akselos's technology is particularly beneficial for asset-centric industries such as upstream oil and gas and offshore wind, where real-time monitoring and predictive maintenance are critical. The platform's patented algorithms provide simulations that are significantly faster than traditional methods, allowing for efficient design and management of critical infrastructure. Akselos also operates a subsidiary in Cambridge, Massachusetts, and maintains a representative office in Vietnam, underscoring its global presence in providing innovative simulation solutions.

Bloom Biorenewables Ltd is a Swiss company established in 2019, specializing in the development of innovative technologies that convert wood and agricultural waste into renewable materials as substitutes for petroleum-based products. The company focuses on producing bio-based materials for various sectors, including fragrances, plastics, and textiles, thereby offering sustainable alternatives to fossil fuels. By introducing a novel approach to the production of biorenewable products and fuels, Bloom Biorenewables aims to make a significant impact in promoting the use of sustainable resources and addressing climate change challenges.

Nagi Bioscience SA is a Swiss company based in Lausanne that specializes in developing and manufacturing an innovative automated testing device utilizing organism-on-chip technology. This device leverages the microscopic worm Caenorhabditis elegans for in vivo testing, enabling pharmaceutical, chemical, and cosmetic companies to assess the toxic and beneficial effects of various substances. By integrating fully automated in vitro handling, culture, and analysis, Nagi Bioscience's platform facilitates toxicity testing, drug discovery, and anthelmintic testing. This approach allows clients to evaluate comprehensive biological responses that can only be observed at the level of the whole organism, thereby transforming traditional testing methodologies.

ROVENSO is a Swiss company founded in 2016 and headquartered in Villaz-Saint-Pierre, Switzerland, with additional facilities in Shenzhen, China. The company specializes in the development and manufacturing of remotely operated robots designed for challenging environments, focusing on security monitoring, safety assessment, and anomaly detection. Its flagship product, ROVéo, is a four-wheeled rover capable of operating autonomously around the clock in industrial settings, providing cost-effective security solutions that are two to three times more efficient than traditional manned guarding. ROVéo is equipped to patrol both indoor and outdoor spaces, detecting intrusions, thefts, and potential safety hazards such as fires or gas leaks, which can be critical for protecting lives and property. ROVENSO's innovations also include a lightweight immersive control station, LISéo, which enhances the operational capabilities of its robotic systems.

Intelistyle Ltd. is an artificial intelligence fashion stylist founded in 2017 and based in London, United Kingdom. The company specializes in providing personalized styling recommendations through its AI-driven platform, designed to assist omnichannel fashion retailers. Its software includes features such as "Complete the Look," which generates multiple outfit combinations for selected items, and a chatbot that offers personal styling advice. Additionally, it provides alternatives for out-of-stock garments and helps manage customer wardrobes. Trusted by prominent brands like D&G, MaxMara, and Tommy Hilfiger, Intelistyle enhances digital discovery experiences, leading to increased conversion rates, larger basket sizes, and higher repeat purchase rates. The platform's ability to understand individual style preferences allows it to outperform human stylists, delivering significant revenue growth for its clients.

Rapid Graft, established in 2018 and based in Zurich, Switzerland, specializes in developing innovative medical devices for precise skin graft harvesting. Their flagship product is a novel dermatome designed to efficiently obtain small split-skin grafts, aiming to enhance chronic wound treatment and facilitate future tissue engineering needs. The company's device enables surgeons to perform skin grafting procedures more effectively, minimizing the risk of infection, scarring, and requiring fewer specialized interventions or operating room resources.

LIfT BioSciences is a biotechnology company based in London, established in 2016, that specializes in advanced innate immuno-cell therapies. It has developed a unique platform known as Neutrophil Only Leukocyte Infusion Therapy (N-LIfT), which enables the production of Immunomodulatory Alpha Neutrophils (IMANs) from induced pluripotent stem cells (iPSCs). This technology aims to address the limitations of existing therapies for solid tumors by utilizing CAR neutrophil cell therapy. The IMANs can alter the tumor microenvironment, enhancing the immune response and enabling a more effective attack on tumors. By leveraging proprietary enhancement media and genetic engineering, LIfT BioSciences seeks to significantly increase the cancer-fighting capabilities of these cells, offering patients the potential for improved outcomes and lasting immunity against cancer.

ALAnostics is a specialty biopharmaceutical company that originated as a spin-off from the University of Geneva. It focuses on developing innovative tumor painting technology aimed at enhancing the surgical treatment of breast cancer. The company’s proprietary approach utilizes nanomedicines to create a fluorescent dye that targets early-stage tumors, facilitating real-time identification and removal during surgery. This technology, based on 5-ALA prodrugs, supports fluorescence-guided surgical procedures and incorporates light-activated antimicrobials, ultimately improving surgical outcomes and increasing the likelihood of saving patients' lives by ensuring complete tumor removal.

Kejako SA is a Swiss company, founded in 2015 and based in Plan-les-Ouates, that specializes in the research and development of medical devices for the ophthalmic surgery sector. The company focuses on addressing presbyopia, a condition that leads to the gradual loss of visual accommodation, through innovative solutions. Kejako offers a unique, non-invasive approach that combines simulation and minimally invasive treatment techniques, utilizing a full eye 3D parametric model and multi-physics numerical modeling to accurately compute the eye's optical and mechanical behavior. This technology enables patients to plan and control customized procedures aimed at preserving their quality of life as they age.

Aspivix SA is a Swiss company founded in 2015, specializing in the development of minimally invasive surgical instruments for gynecology. Headquartered in Lausanne, the firm focuses on creating a new generation of medical devices that enhance the safety and comfort of gynecological procedures. Its flagship product, CAREVIX, employs innovative suction technology to facilitate the painless placement of intra-uterine contraceptive devices and other gynecological interventions. This device is specifically designed to reduce cervical bleeding and minimize the risk of lesions and cross-infections, ultimately safeguarding patient health. By replacing traditional methods such as the use of forceps with its patented suction pad technology, Aspivix aims to transform gynecological care, providing gentler solutions for both women and healthcare providers.

Onto Ltd is a Birmingham-based electric vehicle subscription service founded in 2017. Originally known as EVezy, the company rebranded in July 2020. Onto offers an all-inclusive solution for driving electric cars, allowing customers to subscribe to a vehicle without the burdens of ownership. The subscription covers essential services such as insurance, breakdown support, wear and tear repairs, servicing, charging solutions, and road tax. This model enables users to enjoy the benefits of driving an electric vehicle while avoiding long-term commitments, making the transition to electric driving more accessible and hassle-free. Co-founders Rob Jolly and Dannan O’Meachair established Onto to facilitate a seamless switch to electric mobility.

Lab-on-Fiber GmbH is a German company based in Halle that specializes in the development, commercialization, and production of advanced fiber delivery and laser systems for medical applications. The company focuses on creating smart medical laser probes that are designed to enhance outcomes in minimally invasive surgeries. Its product offerings include surgical and urology fiber probes, which utilize optimized radiation profiles and temperature monitoring at the probe surface. These innovations aim to improve patient safety, reduce operating times, and increase the success rate of treatments, thereby addressing key challenges in laser surgery.

FLYLA GmbH, founded in 2018 and based in Munich, Germany, specializes in providing online booking solutions tailored for students and young travelers. The company connects with airlines to establish student fares, which serve as a revenue management tool, and distributes these fares to its expanding network of enrolled university students. By simplifying travel arrangements through its online booking software, FLYLA enables users to access discounted travel deals, facilitating bookings by allowing the submission of travel details and online payments. This approach addresses the financial constraints many students face in affording air travel, thereby promoting greater access to travel opportunities for the youth.

Aesyra SA is a Swiss company founded in 2017 and headquartered in Lausanne. It specializes in the design and manufacture of medical devices, particularly the AesyBite, an intra-oral sensor that monitors and alleviates sleep bruxism. Aesyra's technology is aimed at assisting dental professionals by reducing damage to dental prostheses caused by occlusal issues. The company focuses on enhancing the care of individuals with sleep disorders by providing tools that perform intraoral measurements during sleep. These measurements help in detecting bruxism, obstructive sleep apnea, and other related conditions. Through its innovative solutions, Aesyra enables healthcare professionals to accurately monitor patient activities and implement biofeedback treatments to improve sleep quality.

Parquery AG is a Swiss start-up based in Zurich, founded in 2014. The company specializes in smart parking solutions through its cloud-based image analysis software. Utilizing computer vision and machine learning, Parquery's technology processes images from existing cameras to detect real-time availability of on-street parking spaces. This innovative web application provides users with real-time vacancy data and smart routing options, aiding drivers in locating available parking spots efficiently. Additionally, Parquery's solutions offer parking managers insights into the historical, current, and predictive usage of their facilities, contributing to enhanced smart city and smart mobility initiatives.

Heepsy is a developer of an influencer marketing platform that facilitates connections between brands, agencies, and influencers. Founded in 2016 and headquartered in Bilbao, Spain, the company offers tools for businesses to discover Instagram influencers tailored to specific campaign themes, locations, follower counts, and engagement rates. By enabling targeted searches, Heepsy's platform helps brands identify authentic influencers who align with their marketing objectives, thereby enhancing the effectiveness of their campaigns.

Letos is a computer software startup founded in 2016 and based in Brandenburg, Germany. The company specializes in behavioral sciences, affective neuroscience, and well-being technologies. Letos develops machine learning technology that predicts user behavioral reactions through the use of biosensors and advanced machine learning techniques. This platform captures genuine spontaneous emotional responses, allowing organizations to assess user satisfaction, alertness, and overall well-being while ensuring total user anonymity. By focusing on technological advancements that prioritize the human user, Letos aims to enhance understanding of user experiences in various contexts.

MagicTomato operates an online grocery marketplace focused on providing locally sourced and made products. Established in September 2016 in the Geneva area, the company aims to promote sustainable grocery shopping by offering a range of non-industrial and GMO-free items, including fruits, vegetables, meats, cheeses, and beverages. The marketplace features over 800 products sourced from a network of approximately 30 local artisans, ensuring ultimate freshness and quality. MagicTomato's business model emphasizes reducing food waste and packaging, while facilitating same-day delivery to customers. With a commitment to enhancing consumer access to healthy and smart grocery options, the company has achieved break-even status.

GliaPharm SA is a Swiss biotechnology company focused on developing innovative treatments for neurological and psychiatric disorders. Established in 2016 and headquartered in Geneva, GliaPharm specializes in targeting glial cells, which are the support cells of neurons, to enhance brain metabolism in pathological conditions. The company utilizes its GliaX technology platform to identify drugs that influence glial cell activity and brain energy metabolism. This platform incorporates high throughput screening technologies, metabolic tests for in vitro and in vivo assessments, and various rodent models to study neurological diseases such as Alzheimer's disease, amyotrophic lateral sclerosis, and other psychiatric conditions. Through its research and development efforts, GliaPharm aims to provide healthcare providers with novel therapeutic options for patients suffering from these disorders, positioning itself as a leader in glia-mediated neuroprotection and cognitive function maintenance.

Alogo Analysis SA is a Swiss company established in 2016, focused on developing advanced analytics tools for the equine industry, particularly in equestrian sports like show-jumping. Based in Apples, Switzerland, Alogo Analysis aims to modernize the discipline by offering innovative solutions that quantify the performance of horses and monitor their health and locomotion. One of its key products, Move, allows users to collect and analyze performance data, facilitating a deeper understanding of equine athletes. By providing novel performance statistics, Alogo Analysis enhances the training experience and improves engagement for spectators and fans at high-level international competitions. Through its commitment to leveraging technology in equestrian sports, the company seeks to elevate the overall experience for both athletes and audiences alike.

RiskTalk Ltd is a company that specializes in developing a communication tool aimed at enhancing employee engagement by allowing them to voice concerns related to their workplace values and priorities. Founded in 2016 and headquartered in Lausanne, Switzerland, with an additional office in Kent, United Kingdom, RiskTalk offers enterprise software that facilitates bottom-up communication, enabling employees to report issues in a blame-free environment. This innovative tool captures and logs risks within organizations, empowering management to allocate responsibilities, provide feedback, and monitor the resolution of problems in real-time. By fostering open dialogue, RiskTalk helps organizations better understand the realities faced by their employees, ultimately turning communication into actionable solutions.

Social Fabric is a sustainable textile center committed to promoting the use of textiles and clothing that minimize ecological and social footprints. The company operates a community-based association that emphasizes the integration of refugees in Switzerland and sustainability in textile production. Through its atelier, Social Fabric aims to provide customers with meaningful and customized garments that reflect principles of a circular economy, innovative technology, and ethical labor practices. By combining decentralised manufacturing with a focus on sustainability, Social Fabric enables individuals to access high-quality, sustainable textile products tailored to their needs.

Skypull SA is a Swiss company established in 2013, focused on developing an innovative airborne wind energy system that harnesses high-altitude winds to generate electricity. The company has designed a hybrid drone capable of vertical take-off and landing, which operates at greater altitudes where winds are stronger and more consistent. This drone is connected to a ground-based generator via a tether, allowing it to capture and convert wind energy into clean power. Skypull's proprietary airframe technology provides enhanced efficiency and resilience, making the system more versatile than competitors. By leveraging this technology, the company aims to offer an affordable, renewable energy solution that addresses climate change and promotes the transition from fossil fuels to sustainable energy sources.

ChemAlive SA is a Swiss company founded in 2014 that operates a cloud-based computational chemistry platform. This platform automates the calculation of quantum data for molecular properties and synthetic reactions, allowing chemists to generate accurate analytics from standard 2D chemical inputs. By leveraging managed cloud computing, in-house automation algorithms, and a comprehensive database, ChemAlive provides valuable insights for various sectors, including academic research, pharmaceuticals, fine chemicals, and contract research organizations. The company's services simplify the research and development process, enabling chemists to design experiments more effectively and address complex challenges efficiently. With plans to incorporate machine learning and big data concepts, ChemAlive aims to significantly reduce the time required to obtain reliable chemical information, transforming the way chemists approach their work and enhancing decision-making in chemical sales and marketing environments.